TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Feb, 4, 2023
It’s not just the efficacy and safety of the produ... See more
Dec, 30, 2022
The analyst comments "TGTX stock is up >15... See more
Mar, 22, 2023
$COST almost!
Mar, 22, 2023
$COST this dude 🤡🤣🤣🤣
Mar, 22, 2023
$COST The bullish trend in the options market suggests a positive outlook for the stock We are seeing the $450 CALL having heavy activity which expire in 38 days.
Mar, 21, 2023
$COST 💵long 💅
Mar, 20, 2023
$COST 🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣
Mar, 20, 2023
$COST nice wedge here 🫡🔒 all I gottta say 🤫
Mar, 18, 2023
$COST Love Costco as much as anyone
Mar, 17, 2023
$COST 2hr looking bullish, she wanna touch the 200 day which is 296, juicy
Mar, 16, 2023
$COST The chart points towards an optimistic outlook for the stock.
Mar, 15, 2023
$COST Always a buy in the 470s, congratulations to those who got it this a.m.
Feb, 6, 2023
costs nothing to hold ladies.
Feb, 6, 2023
however, Tesla is 3% with substantially less cost to borrow.
Feb, 5, 2023
Buy and hold until you’re happy w your cost basis
Feb, 1, 2023
Your cost is now lower as well 😂.
Jan, 26, 2023
Cost down to $28.73… Will keep buying til I cant afford the stock price. lol
Jan, 26, 2023
Got my cost down to $29.61.
Jan, 20, 2023
Improved supply chain means lower costs and higher margins.
Jan, 8, 2023
SSR + High Cost to Borrow + High FTDs due on 11th (over $1 million) + Trending = GOOD CHANCE FOR NICE PRICE POP💰💰💰 https://www.warriortrading.com/short-sale-restriction-ssr-fast-explanation/
Jan, 7, 2023
$HKD Cost to borrow rapidly increasing now at 221% only 60K shares awailable, primed to run next week 🚀🚀🚀🚀🚀🚀🚀
Nov, 4, 2022
$HKD had to take some $ on the run up and buy back lower - feeling pretty good now with a cost basis of 20$ - next run should be massive IMO 🫡
Feb, 4, 2023
It’s not just the efficacy and safety of the product, it is the less cost for hospital/infusion, due to one hour infusion and the huge difference in price.
Dec, 30, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
Dec, 30, 2022
Each treatment cost under $10k per treatment.
Dec, 30, 2022
Each treatment cost under $10k per treatment.
Dec, 29, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,